In the present study we describe the isolation, structural characterization, and developmental expres- 
INTRODUCTION
Peptide-YY is a 36-amino acid hormone produced primarily by endocrine cells in the colon, ileum, and pancreas (1) (2) (3) (4) (5) (6) (7) (8) . The secretion of this peptide is influenced by a number of nutritional factors, the most important of which is the presence of fatty acids in the intestine (6, 9) . Fat-stimulated release of peptide-YY appears to result from both a direct effect on intestinal peptide-YYproducing cells as well as neuroendocrine signals that 0888-8809/91 /0433-0440$03.00/0 Molecular Endocrinology Copyright © 1991 by The Endocrine Society arise from the foregut (6, (9) (10) (11) . Administration of peptide-YY to experimental animals has widespread effects on the gastrointestinal tract, including inhibition of gastric acid secretion and gastric emptying, inhibition of digestive enzyme secretion by the pancreas, and inhibition of small intestinal motility (1, 2, (12) (13) (14) .
The amino acid sequence of peptide-YY is similar to those of two other regulatory peptides, pancreatic polypeptide, a pancreatic islet hormone, and neuropeptide-Y, a neurotransmitter that is distributed throughout the central and peripheral nervous systems. The amino acid sequences of the precursors for peptide-YY, pancreatic polypeptide, and neuropeptide-Y have been deduced from recombinant cDNAs (15) (16) (17) (18) (19) . All three peptide precursors share a highly conserved structural organization, suggesting that each arose from the duplication of a common ancestral gene.
Peptide-YY appears to be produced in multipotential endocrine cells that also synthesize glucagon, suggesting that the expression of these genes is regulated by similar mechanisms. Numerous studies have revealed the presence of peptide-YY immunoreactivity in glucagon-producing cells of the distal intestinal tract and pancreatic islets of many vertebrate species, including amphibia, reptiles, and fish (4, 5, 20) . Although peptide-YY and glucagon appear to be colocalized in endocrine cells of intestine and pancreas of adult animals, the ontogeny of peptide-YY and glucagon gene expression in these tissues has not been fully characterized.
To further understand the evolution of the pancreatic polypeptide gene family and to begin to understand the regulatory mechanisms controlling peptide-YY expression, we have isolated and structurally characterized the rat peptide-YY gene. To further elucidate the relationship between peptide-YY and glucagon, we have examined the developmental pattern of peptide-YY and glucagon gene expression in rat intestine and pancreas. isolated rat peptide-YY cDNA (19) was used as a hybridization probe to screen a rat genomic library constructed in bacteriophage ACharon 4A. The probe identified a single recombinant out of 10 6 plaques screened. A single 4.5-kilobase (kb) Kpn\ restriction fragment hybridized to the oligonucleotide probe in Southern blot hybridization assays. Because our previously isolated cDNA (19) did not include sequence in the 5' untranslated region, we were unable to conclusively show that the entire peptide-YY gene was contained in the genomic bacteriophage clone. To obtain sequence corresponding to the 5' untranslated region of the mRNA, we constructed and screened a rat colonic bacteriophage Xgt11 cDNA library with the 30-bp oligonucleotide. We identified 17 recombinants out of 850,000 plaques screened. One recombinant was sequenced, and a 21-bp oligonucleotide (5'-GCCTTCCATCTCCTCCTGCTC-3') corresponding to 5' untranslated sequence was synthesized. This oligonucleotide probe also hybridized to the 4.5-kb Kpn\ restriction fragment, indicating that the genomic bacteriophage clone contained all of the exons of the peptide-YY gene.
Genomic Southern Blot Analysis of the Rat Peptide-YY Gene
Restriction endonuclease analysis of genomic DNA was performed by Southern blotting, using the full-length peptide-YY cDNA probe (Fig. 1A) . The restriction fragments recognized by the probe were identical to those predicted from the restriction map of the cloned gene (Fig. 1B) . Since the probability of obtaining an identical restriction map from a second copy of the peptide-YY gene is extremely low, we conclude that there is only a single gene encoding peptide-YY in the rat genome, and that the cloned gene does not contain any major rearrangements.
Nucleotide Sequence Analysis of the Rat Peptide-YY Gene
Approximately 2.7 kb of the 4.5-kb Kpn\ fragment containing the peptide-YY gene were sequenced using the strategy depicted in Fig. 1B . The Kpn\ subclone contained approximately 0.9 kb of bacteriophage DNA at its 5' end. The complete nucleotide sequence of the peptide-YY gene, including 550 bp of 5' flanking sequence, is shown in Fig. 2 . Comparison of the sequence of the rat peptide-YY gene with the nucleotide sequence of the cloned cDNA reveals that the gene is divided into four exons, 94,188, 84, and 164 nucleotides in length, separated by three introns, 404,107, and 109 nucleotides in length. Characteristic GT/AG splice-donor and acceptor sites are present at each intron-exon junction. The nucleotide sequences of the exons agree with the sequence of the cDNA reported previously (19) .
Each exon in the rat peptide-YY gene encodes a functional domain of the mRNA (Fig. 2) , as is the case for the genes encoding the related peptides, pancreatic A. polypeptide and neuropeptide-Y. Exon 1 of the peptide-YY gene encodes the entire 5' untranslated region, but none of the translated portion of the peptide-YY mRNA. Exon 2 begins precisely with the first base of the codon encoding the methionine residue at the translational initiation site and encodes the signal peptide and most of the mature hormone. This exon terminates with the first two bases of the codon for arginine-35 near the Cterminus of peptide-YY. The third exon begins with the third base of the arginine codon, followed by the codons for the C-terminal tyrosine of peptide-YY, a Gly-Lys-Arg amidation-cleavage sequence, and the first 24 amino acids of the C-terminal peptide. Exon 4 encodes the remaining seven amino acids of the C-terminal peptide and all of the 3' untranslated region of the mRNA, including the polyadenylation addition site.
Transcriptional Initiation Site of the Rat Peptide-YY Gene
The site of transcriptional initiation was determined by primed cDNA synthesis using an end-labeled 30-bp oligonucleotide complementary to sequence encoding a portion of the signal peptide. The lengths of the cDNA transcripts were determined by electrophoresis on an 8% denaturing polyacrylamide gel (Fig. 3) . The major cDNA product was 139 bp in length, terminating at a position 26 bp down-stream of the first T of the TATA sequence.
Developmental Expression of the Rat Peptide-YY Gene
The ontogeny of peptide-YY gene expression was investigated in the intestine and pancreas of developing rats by Northern blot hybridization assays. Peptide-YY mRNA was readily detected in the fetal duodenum, ileum, colon, and pancreas, but not in the jejunum. Peptide-YY mRNA in colon was first detected on day 17 of gestation and reached adult levels 3 days later (Fig. 4A) . In the ileum, the time course of peptide-YY gene expression was similar to that in the colon, although the mRNA abundance was lower (data not shown). Peptide-YY mRNA was first identified on day Because peptide-YY and glucagon are colocalized in endocrine cells of intestine and pancreas, we compared the developmental expression of the glucagon gene to that of peptide-YY. We found that the time course of glucagon gene expression in ileum and colon was similar to that of peptide-YY. Glucagon and peptide-YY mRNA were first detected on day 17 in the colon, rising to adult levels 3 days later (Fig. 4A) . The time course of glucagon gene expression in the pancreas, however, differed from that of peptide-YY. In this tissue, glucagon mRNA levels were highest after birth, whereas peptide-YY mRNA levels were highest several days before birth (Fig. 4B) .
DISCUSSION
In the present study we have isolated and structurally characterized the gene encoding rat peptide-YY. The transcriptional unit of this gene spans approximately 1.2 kb and is present in a single copy in the rat genome. The structural organization of the rat peptide-YY gene All Northern blots were probed sequentially with a peptide-YY cRNA probe, a glucagon cDNA probe, and a /?-actin cDNA probe (not shown). Blots containing total RNA from colon (12.5 ng) and pancreas (7.5 ng) are shown in A and B, respectively. In the Adult lanes indicated at the right of B, 25 ng RNA from whole pancreas (P) and 5 ng RNA from pancreatic islets (I) were loaded onto the gel. All blots were exposed to Kodak XAR film overnight using two intensifying screens at -85 C, except for the glucagon-probed blot loaded with RNA from colon (A), which was exposed to the film for 72 h with two intensifying screens. C shows a quantitative determination of peptide-YY mRNA on a Northern blot that was loaded with equal amounts of total RNA (7.5 ng) from developing colon and pancreas. The amount of radioactivity in the band corresponding to peptide-YY mRNA was quantitated using a blot analyzer, as described in Materials and Methods.
is similar to that of the genes encoding pancreatic polypeptide and neuropeptide-Y (21-25). All are characterized by four exons, separated by three introns, in which each exon defines a functional domain of its mRNA (Fig. 5) . The splice-donor site for the third intron of the rat peptide-YY gene occurs at an arginine residue in the C-terminal peptide, similar to the third exons of the rat and human neuropeptide-Y and human pancreatic polypeptide genes (21) (22) (23) . Although an analogous arginine residue has been suggested to serve as a cleavage site in the pancreatic polypeptide precursors of several species (26), it is not known whether the peptide-YY precursor is cleaved at this site.
The amino acid sequence similarity among neuropeptide-Y, pancreatic polypeptide, and peptide-YY as well as the conserved structural organization of the respective polypeptide precursors and genes suggest that each member of this family arose from the duplication of a common ancestral gene. In the human, the neuropeptide-Y and pancreatic polypeptide genes have been localized to chromosomes 7 and 17, respectively, suggesting that this gene family originated from a tandem duplication of an ancient linkage group, followed by chromosomal translocation (27) . Several other gene families segregate similarly to pancreatic polypeptide and neuropeptide-Y (28) . Genes encoding erbA, erbB-B2, Hox\, «1-chain type 1 collagen, erythyroid band 3, and protein kinase-C localize on chromosome 17 along with pancreatic polypeptide. The erbB, HoxW, «2-chain type 1 collagen, /3-actin, nonerythroid band 3, and protein kinase-A localize to chromosome 7 with neuropeptide-Y. The protein kinase-A and /3-actin genes are themselves duplicated on chromosome 7, leading to the speculation that the human peptide-YY gene may localize to chromosome 7 as well.
Examination of the flanking regions of the rat peptide-YY gene reveals several sequences similar to c/s-acting elements which respond to specific intracellular signalling pathways dependent on protein kinase-A and protein kinase-C. In the 5' flanking sequence, a potential AP-1 binding site was localized 144 bp up-stream from the transcriptional initiation site (Fig. 2) . However, this site (AAAGTCAG) shares only six of eight bases with the AP-1 consensus sequence (TGAGTCAG) (29, 30) , and it is, therefore, uncertain whether this c/s-acting element is functionally active. Four C-rich domains were localized within 130 bp of the transcriptional initiation site (Fig. 2) , which could potentially serve as binding sites for AP-2, an inducible transcription factor that also activates gene transcription through specific intracellular signalling pathways (31, 32) . A potential cAMPresponsive element (CRE) that shares seven bases (TGGCGTCA) with the eight-base consensus sequence (TGACGTCA) (33) was identified 63 bp down-stream from the polyadenylation signal in the 3' flanking sequence (Fig. 2) . Although CREs have been shown to function independently of position and orientation (34), it is not clear whether the element in the 3' flanking sequence of the peptide-YY gene functions in this unusual location. The effects of activation of specific intracellular signalling pathways on the transcriptional regulation of gene expression are mediated by frans-acting factors, such as AP-1, AP-2, and CRE-binding protein (29) (30) (31) (32) (33) (34) . The presence of sequences potentially capable of binding to these frans-activating factors in the peptide-YY flanking sequences may indicate that peptide-YY gene expression is regulated by protein kinase-Aand protein kinase-C-dependent intracellular signalling pathways.
In this study we present evidence that peptide-YY gene expression is developmentally regulated. The observation that peptide-YY gene expression is highest before birth was an unanticipated finding considering that gut hormone production is believed to be controlled by enteral and nutritional stimuli that are not present before birth. Furthermore, we have shown that the pancreas is quantitatively a major site of peptide-YY mRNA synthesis in fetal animals. These studies revealed that peptide-YY mRNA levels in the fetal pancreas were up to 7-fold higher than those in the colon. Finally, we found that the peptide-YY gene is differentially regulated in the developing intestine and pancreas. Expression of the peptide-YY gene in the pancreas declines dramatically after birth, in contrast to the situation in the intestine, where the level of peptide-YY gene expression is maintained. Our observations are in general agreement with earlier reports that qualitatively demonstrate the presence of peptide-YY in intestinal and pancreatic endocrine cells by immunocytochemistry on day 19 of gestation in the colon (3) and on day 14 of gestation in islets (4) . The postnatal decline in peptide-YY gene expression in developing pancreas closely parallels the disappearance of gastrin and TRH mRNA from islets after birth (35, 36) .
Peptide-YY has been implicated as an intestinal growth-promoting factor, since increased secretion of peptide-YY has been associated with experimentally induced intestinal epithelial cell proliferation (37) (38) (39) . Administration of epidermal growth factor to rats maintained on total parenteral nutrition has been shown to significantly increase the mass of the proximal intestine as well as circulating peptide-YY levels (39) . Similarily, massive small bowel resection has been associated with crypt cell proliferation in the remaining small intestine and a 3-fold increase in circulating peptide-YY levels (37) . The time course of peptide-YY gene expression in developing animals reported here is consistent with a potential trophic role for this hormone at a time when the gastrointestinal tract is undergoing rapid growth.
Peptide-YY immunoreactivity has been colocalized with glucagon-like immunoreactivity in endocrine cells of intestine and pancreas (4, 5, 20) , suggesting that these two cell types are derived from a common lineage. The time course of peptide-YY gene expression in ileum and colon was similar to that of glucagon, whereas in the pancreas, the developmental pattern of peptide-YY gene expression differed from that of glucagon (Fig. 4,  A and B) . This divergent pattern of peptide-YY and glucagon gene expression in the developing rat pancreas is supported by observations in human pancreas. Whereas peptide-YY immunoreactivity is present in considerable amounts 20 weeks postconception and declines linearly from 20-39 weeks, glucagon immunoreactivity remains constant over the same time interval (4). Our observations suggest that peptide-YY and glucagon gene expression are developmentally regulated by similar mechanisms in the intestine, but by different mechanisms in the pancreas.
MATERIALS AND METHODS

Isolation and Subcloning of the Rat Peptide-YY Gene
A 30-bp oligonucleotide (5'-GCAGCATTGCGACCATA-ACGGGCCAAGGCC-3') corresponding to a sequence in the coding region of the signal peptide of the peptide-YY cDNA was synthesized (381A DNA Synthesizer, Applied Biosystems, Foster City, CA) and used as a probe to screen a partial Haelll rat genomic library constructed in bacteriophage XCharon 4A (40) . The oligonucleotide was end labeled with T4 polynucleotide kinase (U.S. Biochemical Corp., Cleveland, OH). Hybridizations were carried out at 50 C in 6 x SSC (1 x SSC = 0.12 M NaCI and 0.015 M sodium citrate, pH 7.0) containing 5 x Denhardt's solution (1 x Denhardt's = 0.02% Ficoll, 0.02% BSA, and 0.02% polyvinylpyrrolidone), as described by Benton and Davis (41) . Filters were washed in 2 x SSC and 0.1% sodium dodecyl sulfate (SDS) at room temperature and in 0.2 x SSC and 0.1% SDS at 42 C. Positive clones were plaque purified by sequential low density plating, and bacteriophage DNA was prepared by the plate-lysate method (42) . A single 4.5-kb Kpn\ restriction fragment of the bacteriophage DNA, identified by Southern blot hybridization, was subcloned into plasmid vectors for further analysis.
Isolation of a Full-Length Peptide-YY cDNA
Since our previously isolated cDNA did not include sequence corresponding to the 5' untranslated region (19), we were unable to establish whether the entire peptide-YY gene was contained in the bacteriophage clone. Therefore, to identify mRNA sequence in the 5' untranslated region, we needed to obtain a full-length cDNA clone. We, therefore, constructed an adult rat colonic cDNA library in bacteriophage Xgt11. After first strand synthesis using Moloney murine leukemia virus (MMLV) reverse transcriptase, second strand cDNA synthesis was carried out with RNase-H and the large fragment of DNA polymerase-l (Bethesda Research Laboratories, Inc., Gaithersburg, MD) (43) . Linker adapters containing internal Sa/I sites and EcoRI ends were constructed from two synthetic oligonucleotides (5'-AATTCGTTGTCGACTGTCAG-3' and 5'-CTGACAGTCGACAACG-3'), and blunt-end ligated to the cDNAs. The cDNAs were then ligated into EcoRI sites of bacteriophage XgtH DNA arms and packaged into phage particles. The library contained 4 x 10 6 primary bacteriophages, 99% of which contained inserts.
Genomic Southern Blot Hybridization Assay
Rat liver genomic DNA (10 ^g) was digested with different restriction enzymes, electrophoresed on a 0.9% agarose gel, and transferred to a Nytran membrane (Schleicher and Shuell, Keene, NH) by capillary blotting. The filter was hybridized at 70 C with the full-length peptide-YY cDNA probe and washed in 2 x SSC and 0.1% SDS at 23 C and in 0.2 x SSC and 0.1% SDS at 70 C. Filters were exposed to Kodak XAR film at -8 5 C for 48 h with one intensifying screen.
DNA Sequencing
Restriction fragments of the rat peptide-YY cDNA and gene were subcloned into M13 DNA to generate single stranded inserts for DNA sequencing. The nucleotide sequence was determined by the chain termination method using T7 DNA polymerase (U.S. Biochemical Corp.) (44) . Computer-assisted nucleotide sequence analysis was performed as described by Devereux ef al. (45) .
Determination of the Transcriptional Initiation Site
The transcriptional initiation site of the peptide-YY gene was determined by primer extension analysis. Six micrograms of poly(A) + RNA from rat colon were hybridized to 0.75 pmol of the end-labeled 5'-directed 30-bp primer at 55 C for 3 h. Extension was carried out at 37 C for 1 h using MMLV reverse transcriptase. The primer-extended cDNA product was analyzed by electrophoresis on an 8% urea-polyacrylamide gel along with labeled size markers.
Northern Blot Hybridization Assays
Peptide-YY gene expression in intestine and pancreas was investigated in fetal, postnatal, and adult Sprague-Dawley rats (Taconic Farms, Germantown, NY) by Northern blot hybridization assays. Intestinal tissues were immediately frozen in liquid nitrogen after removal and stored at -7 0 C. Total RNA from intestine was prepared using the acid-phenol method (46) . Total RNA from pancreatic tissue was prepared immediately upon removal by the lithium chloride precipitation method (47) . To assure that equal amounts of RNA were loaded onto gels for Northern blotting experiments, RNA was quantitated by the absorbance at 260 nm and by the UV fluorescence intensity of the ribosomal RNA subunits on nondenaturing agarose gels stained with ethidium bromide. After electrophoresis on 1.3% denaturing agarose gels, RNA was transferred to Nytran membranes by capillary blotting. Hybridizations were carried out in 50% formamide at 65 C with an antisense The Rat Peptide-YY Gene 439 peptide-YY cRNA probe (19) . To reduce the likelihood of crosshybridization with pancreatic polypeptide, we used a probe that shared only 46% homology with rat pancreatic polypeptide mRNA. The relative abundance of peptide-YY mRNA on Northern blots was determined by measuring directly the radioactivity emitted from the bands corresponding to peptide-YY mRNA, as visualized on a Betascope 603 Blot Analyzer (Waltham, MA) (48, 49) . Values obtained were corrected for background radioactivity. After removal of the peptide-YY probe by high temperature, low salt washing, the blots were hybridized in 50% formamide at 42 C with a glucagon cDNA probe (50) . To verify that equal amounts of mRNA were loaded onto each lane, the blots were also probed with /3-actin.
Preparation of Pancreatic Islets
Pancreatic islets were isolated from adult rats by in situ collagenase (Sigma Chemical Co., St. Louis, MO) perfusion, followed by centrifugation in discontinuous dextran gradients, as described previously (51) . Islets were manually separated from any remaining acinar tissue under a dissecting microscope. Islets from eight rats were pooled and frozen until RNA was prepared by the lithium chloride precipitation method (47) . All animal experiments were conducted in accord with the principles and procedures outlined by the NIH Guidelines for Care and Use of Experimental Animals.
